What are patients' attitudes towards generic drugs ? The example of metformin;Quelles sont les attitudes des patients vis-à-vis des médicaments génériques ? Illustration par la metformine

Revue Medicale Suisse

Volumn 9, Issue 385, 2013, Pages 1005-1009

  Allenet, Benoît ^a,b   Golay, Alain ^b  

^a UNIV GRENOBLE ALPES   (France)

^b Département de Médecine Communautaire   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; METFORMIN;

ARTICLE; COST CONTROL; DRUG CHOICE; DRUG COST; DRUG INFORMATION; DRUG QUALITY; FAMILY; FRIEND; HEALTH BELIEF; HUMAN; KNOWLEDGE; MASS MEDIUM; PATIENT ATTITUDE; PERSONAL EXPERIENCE; PRESCRIPTION; TRUST;

DRUGS, GENERIC; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; METFORMIN;

EID: 84878208473     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Guideline on the investigation of bioequivalence, doc. ref. : CPMP/EWP/QWP/1401/98 Rev. 1/Corr 20 January 2010. www.ema.europa.eu/docs/en-GB/ document-library/Scientific-guideline/2010/01/WC500 070039.pdf
2. World Health Organisation. The World health report 2010 : Health systems financing : The path to universal coverage. Geneva, 2010.
3. Kanavos P, Vandoros S, Irwin R, et al. Medical Technology Research Group. Differences in costs of and access to pharmaceutical products in the EU. Brussels : Policy Department Economic and Scientific Policy -European Parliament, 2011.
4. Ordonnance du DFI du 29 septembre 1995 sur les prestations dans l'assurance obligatoire des soins en cas de maladie (Ordonnance sur les prestations de l'assurance des soins, OPAS). RS 832.112.31. Modification diffusée sur le site de l'Office fédéral de la santé publique www.bag.admin.ch/kv/f/index.htm, consulté le 6 mars 2006.
5. D'Agostino F. Médicaments génériques : droit/devoir de substitution, quote-part et potentiel d'économie. Analyse de la législation suisse et comparaison avec d'autres pays d'Europe. Master of Advanced Studies in Health Economics and Management (MASHEM) Oct. 2010; Mémoire N° 151. www.chuv.ch/bdfm/cdsp/85159. pdf
6. Allenet B, Sailly JC. La mesure du bénéfice en santé par la méthode du consentement à payer. J Econ Med 1999;17(Suppl.):301-26.
7. Shrank WS, Stedman M, Ettner SL, et al. Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med 2007;22:1298-304.
8. Chong C, March G, Clark A, et al. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy 2011;99:139-48.
9. Vallès JA, Barreiro M, Cereza G, et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy 2003;65:269-75.
10. Kjoenniksen I, Lindbaek M, Granas AG. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006;28:284-9.
11. Figueiras M, Marcelino D, Cortes M. People's views on the level of agreement of generic medicines for different illnesses. Pharm World Sci 2008;30:590-4.
12. Barrett LL. Physicians' attitudes and practices regarding generic drugs. 2005 (http://assets.aarp.org/rgcenter/health/phys-generic.pdf). (Accessed on 14/03/2008).
13. Decollogny A, Eggli Y, Halfon P, et al. Determinants of generic drug substitution in Switzerland. BMC Health Services Research 2011;11:17. www.biomedcentral.com/1472-6963/11/17
14. Berthier N. Les entretiens. In : N. Berthier, ed. Les techniques d'enquête. Paris : Armand Colin, 1998;51-65.
15. Huberman AM, Miles BW. Analyse des données qualitatives : recueil de nouvelles méthodes. Bruxelles : De Boeck-Wesmael, 1991.
16. Pereira JA, Holbrook AM, Dolovich L, et al. Are brand-name and generic warfarin interchangeable ? A survey of Ontario patients and physicians. Can J Clin Pharmacol 2005;12(Suppl.):e229-39.
17. Hassali MA, Shafie AA, Jamshed S, et al. Consumers' views on generic medicines : A review of the literature. Int J Pharm Pract 2009;17:79-88.
18. Shrank WH, Cox ER, Fischer MA, et al. Patients' perceptions of generic medications : Although most Americans appreciate the cost-saving value of generics, few are eager to use generics themselves. Health Aff (Millwood) 2009;28(Suppl.):546-56.
19. Babar Z, Grover P, Stewart J. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand. Res Social Adm Pharm 2011;7:294-305.
20. Hassali MA, Kong DC, Stewart K. Generic medicines : Perceptions of consumers in Melbourne, Australia. Int J Pharm Pract 2005;13(Suppl.):257-64.
21. Shrank WH, Cadarette SM, Cox E, et al. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization ? Med Care 2009;47(Suppl.):319-25.
22. Quintal C, Mendes P. Underuse of generic medicines in Portugal : An empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy 2012;104:61-8.
23. Babar Z, Awaisu A. Evaluating community pharmacists' perceptions and practices on generic medicines : A pilot study from Peninsular Malaysia. J Generic Med 2008;5:315-30.
24. Allenet B, Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs : Survey of 1,000 French community pharmacists. Pharm World Sci 2003;25(Suppl.):197-202.
25. Kobayashi E, Karigome H, Sakurada T, et al. Patients' attitudes towards generic drug substitution in Japan. Health Policy 2011;99:60-5.
26. Sharrad AK, Hassali MA. Consumer perception on generic medicines in Basrah, Iraq : Preliminary findings from a qualitative study. Res Social Adm Pharm 2011; 7:108-12.
27. Hakonsen H, Eilertsen M, Borge H, et al. Generic substitution : Additional challenge for adherence in hypertensive patients ? Curr Med Res Opin 2009;25:2515-21.
28. Allenet B, Guignon AM, Maire P, Calop J. Intégration des représentations de la personne âgée face à ses médicaments pour améliorer son observance. J Pharm Clin 2005;24(Suppl.):175-9.
29. Sarradon-Eck A, Blanc MA, Faure M. Des usagers sceptiques face aux médicaments génériques. Une approche anthropologique. Rev Epidemiol Sant Pub 2007; 55:179-85.
30. Erdem T, Zhao Y, Valenzuela A. Performance of store brands : A cross-country analysis of consumer store-brand preferences, perceptions, and risk. J Mark Res 2004;41:86-100.
31. www.academie-medecine.fr/Upload/PLACE%20 DES%20GENERIQUES%20DANS%20LA%20PRES CRIPTION%20F.pdf
32. Kapferer JN. Les marques, capital de l'entreprise : créer et développer des marques fortes. Paris : Eyrolles, 2007.
33. Baudrant-Boga M, Allenet B. Inertie thérapeutique : et le patient dans tout ça ? Médecine des maladies métaboliques 2011;5:S73-80.
34. www.medicamentsgeneriques.info/http://www. medicamentsgeneriques.info/wp- content/uploads/2010/03/ENQUETE-MEDECINS-GEMME.pdf
35. Lagarce L, Lusson-Brisset C, Bruhat C, et al. Médicaments génériques, le point de vue des médecins : enquête d'opinion réalisée auprès des médecins libéraux du Maine-et-Loire. Thérapie 2005;60(Suppl.):67-74.
36. Granlund D. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals ? Soc Sci Med 2009;69:1643-50.
37. Coscelli A. The importance of doctors' and patients' preferences in the prescription decision. J Ind Econ 2000;48:349-69.
38. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost : A systematic review. PloS Med 2007; 4(Suppl.):1486-96.
39. Shrank WH, Hoang T, Ettner SL, et al. The implications of choice : Prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med 2006;166:332-7.